NCT07524530

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-06-14Est. Completion: 2033-06-01

Enrollment target: 98 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Contact

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.